Vijaya L. Galic, MD
Primary LocationObstetrics & Gynecology 4801 Alberta Ave.
El Paso, TX 79905
Phone (915) 215-5000
Medical School: University of Washington School of Medicine
- Columbia Presbyterian Medical Center
- Cornell Weill NY Hospital
- New York Presbyterian Medical Center
Residency: Lehigh Valley Health Network
Graduate School: The Johns Hopkins University School of Professional Studies in Business and Education
Undergraduate School: Cornell University College of Agriculture and Life Sciences
- American Board Obstetrics & Gynecology (Gynecologic Oncology)
Dr. Galic is a board certified Gynecologic Oncologist, Assistant Professor, and Division chief of Gynecologic Oncology. She completed her medical education at the University of Washington School of Medicine and an MBA at Johns Hopkins University. Her residency training in Obstetrics and Gynecology was through the Lehigh Valley Health Network. She completed a fellowship in Gynecologic Oncology at the Cornell and Columbia Universities’ joint fellowship program at New York Presbyterian Hospital. Her clinical interests include the management of advanced ovarian cancer, targeted therapeutics and precision medicine, fertility preserving surgery for women with cervical cancer, and palliative medicine. Dr. Galic has authored numerous papers in the field of gynecologic oncology. Her current research interests focus on targetable molecular pathways in ovarian cancer, mechanisms of anti-cancer drug action and the biological basis of drug resistance in ovarian cancer.
Malignant and premalignant conditions of uterus, cervix, ovaries, vulva, morbidly adherent placenta, caccreta/percreta; genetic counseling.
- University Medical Center of El Paso
- The Hospitals of Providence
- Advanced ovarian cancer, intraperitoneal chemotherapy, fertility preserving procedures for cervical cancer, palliative care, minimally invasive surgery.
- Targetable molecular pathways in ovarian cancer, mechanisms of anti-cancer drug action, and the biological basis of drug resistance in ovarian cancer.